PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,760 | -26.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,315 | -29.5% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $18,885 | +15.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $16,330 | -32.9% | 500 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $24,340 | -9.9% | 500 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $27,015 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |